$WVE Wave Life Sciences Ltd. Long term Target PT 39 and higherNASDAQ:WVE Wave Life Sciences Ltd.
Long term Target PT 39 and higher
Wave Life Sciences Ltd., a clinical-stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides tar